Selective inhibition of the cytochrome P450 isoform by hyperoside and its potent inhibition of CYP2D6

Active Tamoxifen Metabolite Plasma Concentrations After Coadministration of Tamoxifen and the Selective Serotonin Reuptake Inhibitor Paroxetine

Vered Stearns · JNCI Journal of the National Cancer Institute · 2003 · 849 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +17

Polymorphism of Human Cytochrome P450 2D6 and Its Clinical Significance

Shufeng Zhou · Clinical Pharmacokinetics · 2009 · 759 citations

Medicine, Genetics, Pharmacology +14

Cytochrome P450 isoform inhibitors as a tool for the investigation of metabolic reactions catalyzed by human liver microsomes.

Martine Bourrié, Viviane Meunier, Yves Berger et al. · Journal of Pharmacology and Experimental Therapeutics · 1996 · 362 citations

Medicine, Biochemistry, Pharmacology +15

Inhibition of human cytochromes P450 by components of <i>Ginkgo biloba</i>

Lisa L. von Moltke, James L. Weemhoff, Ikhlas A. Khan et al. · Journal of Pharmacy and Pharmacology · 2004 · 154 citations · Full text

Medicine, Pharmacology, Biochemical Pharmacology +12

<i>In vitro</i>inhibition of the cytochrome P450 (CYP450) system by the antiplatelet drug ticlopidine: potent effect on CYP2C19 and CYP2D6

Jae Wook Ko, Zeruesenay Desta, Nadia Soukhova et al. · British Journal of Clinical Pharmacology · 2000 · 103 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +16